Merit Research Development from 2010 to 2026
| MMSI Stock | USD 78.86 2.43 2.99% |
Research Development | First Reported 1994-03-31 | Previous Quarter 24.4 M | Current Value 24 M | Quarterly Volatility 7.3 M |
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 138.5 M, Interest Expense of 37.7 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 2.71, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
Merit | Research Development | Build AI portfolio with Merit Stock |
The Research Development trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Merit Medical's Research Development Growth Pattern
Below is the plot of the Research Development of Merit Medical Systems over the last few years. It is Merit Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Merit Research Development Regression Statistics
| Arithmetic Mean | 56,080,046 | |
| Geometric Mean | 44,917,495 | |
| Coefficient Of Variation | 48.78 | |
| Mean Deviation | 22,217,338 | |
| Median | 57,537,000 | |
| Standard Deviation | 27,357,958 | |
| Sample Variance | 748.5T | |
| Range | 99.1M | |
| R-Value | 0.99 | |
| Mean Square Error | 21.9T | |
| R-Squared | 0.97 | |
| Slope | 5,342,911 | |
| Total Sum of Squares | 11975.3T |
Merit Research Development History
About Merit Medical Financial Statements
Investors use fundamental indicators, such as Merit Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Research Development | 96.4 M | 101.2 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Merit Medical Correlation against competitors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Earnings Share 1.95 | Revenue Per Share | Quarterly Revenue Growth 0.13 | Return On Assets |
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.